These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 37171942)
1. Therapeutic Efficacy of Intravitreal Conbercept Injections with or without Focal Macular Photocoagulation for Diabetic Macular Edema. Mao Y; Wang S; Ji X; Cao K; Hou S; Xiao Y Altern Ther Health Med; 2023 Jul; 29(5):308-313. PubMed ID: 37171942 [TBL] [Abstract][Full Text] [Related]
2. One-Year Outcome of Conbercept Therapy for Diabetic Macular Edema. Li F; Zhang L; Wang Y; Xu W; Jiao W; Ma A; Zhao B Curr Eye Res; 2018 Feb; 43(2):218-223. PubMed ID: 29265939 [TBL] [Abstract][Full Text] [Related]
3. Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study. Xu Y; Rong A; Xu W; Niu Y; Wang Z BMC Ophthalmol; 2017 Aug; 17(1):158. PubMed ID: 28841827 [TBL] [Abstract][Full Text] [Related]
4. Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study. Zhang W; Zhao G; Fan W; Zhao T BMC Ophthalmol; 2021 Apr; 21(1):160. PubMed ID: 33789617 [TBL] [Abstract][Full Text] [Related]
5. Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema. Lee HY; Lee SY; Park JS Korean J Ophthalmol; 2009 Sep; 23(3):153-8. PubMed ID: 19794940 [TBL] [Abstract][Full Text] [Related]
6. One-year outcomes of novel VEGF decoy receptor therapy with intravitreal conbercept in diabetic retinopathy-induced macular edema. Zhou Q; Guo C; You A; Wang D; Wang W; Zhang X Mol Vis; 2019; 25():636-644. PubMed ID: 31700228 [TBL] [Abstract][Full Text] [Related]
7. [Treatment response to Conbercept of different types of diabetic macular edema classified based on optical coherence tomography]. Zhang Y; Yao J; Quan Y; Wang J; Xing Y; Zhou A Nan Fang Yi Ke Da Xue Xue Bao; 2021 Oct; 41(10):1501-1508. PubMed ID: 34755665 [TBL] [Abstract][Full Text] [Related]
8. Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China. Liu S; Wang D; Chen F; Zhang X BMC Ophthalmol; 2019 Jul; 19(1):157. PubMed ID: 31337360 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study. Liu K; Wang H; He W; Ye J; Song Y; Wang Y; Liu X; Wu Z; Chen S; Fan K; Liu Y; Zhang F; Li Z; Liu L; Zhang J; Zhang X; Ye J; Liang X; Li X; Ke X; Wu Q; Li J; Tao S; Wang X; Rosenfeld P; Heier JS; Kaiser P; Xu X Br J Ophthalmol; 2022 Oct; 106(10):1436-1443. PubMed ID: 34001667 [TBL] [Abstract][Full Text] [Related]
10. The fellow eye effect of unilateral intravitreal conbercept injections in eyes with diabetic macular edema. Di Y; Li Z; Ye J; Li L; Li B; Yu R Acta Diabetol; 2020 Aug; 57(8):1001-1007. PubMed ID: 32215730 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema. Solaiman KA; Diab MM; Abo-Elenin M Retina; 2010; 30(10):1638-45. PubMed ID: 20838357 [TBL] [Abstract][Full Text] [Related]
12. A systematic review and meta-analysis to compare the efficacy of conbercept with ranibizumab in patients with macular edema secondary to retinal vein occlusion. Liu W; Li Y; Cao R; Bai Z; Liu W Medicine (Baltimore); 2020 May; 99(21):e20222. PubMed ID: 32481293 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal ranibizumab alone or in combination with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy with coexistent macular edema: long-term outcomes of a prospective study. Chatziralli I; Dimitriou E; Theodossiadis G; Kazantzis D; Theodossiadis P Acta Diabetol; 2020 Oct; 57(10):1219-1225. PubMed ID: 32472172 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema. Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA Retina; 2007; 27(9):1187-95. PubMed ID: 18046223 [TBL] [Abstract][Full Text] [Related]
17. Two different initial treatment regimens of Conbercept in diabetic macular edema: 12-month results from a multicenter randomized controlled study. Ren F; Zhang X; Gong H; Tian X; Kong X; Hu Y; Yang J; Shi W; Zhang H; Zhou L; Zhang G Photodiagnosis Photodyn Ther; 2023 Dec; 44():103745. PubMed ID: 37567331 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal Bevacizumab Alone Versus Intravitreal Bevacizumab In Combination With Focal Macular Photocoagulation In Diabetic Macular Oedema. Jatoi AU; Shaikh NA; Narsan AK; Jatoi A J Ayub Med Coll Abbottabad; 2022; 34(1):160-163. PubMed ID: 35466645 [TBL] [Abstract][Full Text] [Related]
19. [Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study]. Arévalo JF; Fernández CF; Mendoza AJ; García RA; Arévalo FA Arch Soc Esp Oftalmol; 2013 Oct; 88(10):373-9. PubMed ID: 24060300 [TBL] [Abstract][Full Text] [Related]
20. Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial. Brown DM; Ou WC; Wong TP; Kim RY; Croft DE; Wykoff CC; Ophthalmology; 2018 May; 125(5):683-690. PubMed ID: 29336896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]